Sanofi India Limited (BOM:500674)

Sanofi India Cash Flow Statement

Financials in millions INR. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	4,133	6,029	6,206	9,444	4,776
Depreciation & Amortization	381	395	411	653	810
Other Amortization	1	1	8	14	12
Loss (Gain) From Sale of Assets	-5	-218	-1,470	-4,958	445
Stock-Based Compensation	12	61	21	61	117
Provision & Write-off of Bad Debts	2	-8	-15	18	4
Other Operating Activities	-933	-3,636	-718	-325	-675
Change in Accounts Receivable	-1,270	6	206	12	52
Change in Inventory	687	-2,558	-314	-336	-222
Change in Accounts Payable	1,662	-669	-280	671	-18
Change in Other Net Operating Assets	-1,365	-269	-68	334	810
Operating Cash Flow	4,615	2,304	3,987	5,588	6,111
Operating Cash Flow Growth	100.30%	-42.21%	-28.65%	-8.56%	48.22%
Capital Expenditures	-364	-343	-222	-230	-414
Sale of Property, Plant & Equipment	6	243	353	105	4
Divestitures	-	-	1,339	5,802	2,394
Other Investing Activities	166	475	589	631	780
Investing Cash Flow	-192	375	6,509	6,308	2,764
Long-Term Debt Repaid	-63	-83	-80	-66	-46
Net Debt Issued (Repaid)	-63	-83	-80	-66	-46
Common Dividends Paid	-3,846	-8,683	-4,169	-2,879	-2,441
Other Financing Activities	-15	-17	-17	-18	-16
Financing Cash Flow	-3,924	-8,783	-15,827	-8,490	-8,100
Miscellaneous Cash Flow Adjustments	-1,606	-	-	-	-
Net Cash Flow	-1,107	-6,104	-5,331	3,406	775
Free Cash Flow	4,251	1,961	3,765	5,358	5,697
Free Cash Flow Growth	116.78%	-47.91%	-29.73%	-5.95%	69.30%
Free Cash Flow Margin	21.12%	9.82%	13.59%	18.12%	19.63%
Free Cash Flow Per Share	184.58	85.15	163.48	232.65	247.37
Cash Interest Paid	15	17	17	18	16
Cash Income Tax Paid	974	2,413	2,607	2,849	1,933
Levered Free Cash Flow	3,640	-400.25	4,207	5,801	7,997
Unlevered Free Cash Flow	3,649	-389.63	4,217	5,812	8,008
Change in Working Capital	-286	-3,490	-456	681	622

Source: S&P Global Market Intelligence. Standard template. Financial Sources.